At-Home kidney care: new study lets diabetes patients test drugs without leaving the house

This study tested whether people with type 2 diabetes and kidney damage can safely participate in a clinical trial from home. Twelve participants took the drug empagliflozin, and depending on their response, some added or switched to finerenone. The goal was to see if remote data collection (urine, blood pressure, weight) is practical and to find the best personalized treatment to lower protein in the urine.